HomeThe Column

The Column

Unique Opportunities at Pharmaceutical Companies Treating Rare Diseases

Philip Carrigan

Kenji Hasegawa was worried about his career. He contacted me out of the blue to ask whether we could meet. This came as somewhat of a surprise to me since it had been several years since we had been in touch. He visited our Nihonbashi office in Tokyo, late on a cold and drizzly January evening after finishing a 13-hour day at work. We exchanged pleasantries. I was keen to understand the urgency behind our meeting since he had not been overly enthused about exploring opportunities outside his present company where he had worked since receiving his master’s degree in pharmacy in 1995. At 45, he was now an associate director of clinical development at a large European pharmaceutical company. He was a one-company guy, and if I were a betting man, I would put my money on the possibility that he would retire at his present firm ...


News Calendar